The Sympathetic Nervous System Modulates Cancer Vaccine Activity through Monocyte-Derived Cells

Area of Science:

• Immunology
• Neuroscience
• Oncology

Background:

• The sympathetic nervous system (SNS) regulates immune cell function, influencing inflammation and antitumor immunity.
• Recent findings suggest the SNS may promote tumor growth and hinder anti-tumor immune responses.
• The precise role of the SNS in modulating antigen-presenting cell (APC) function remains largely unexplored.

Purpose of the Study:

• To investigate the effects of SNS signaling on murine monocyte-derived macrophages (moMФ) and dendritic cells (DCs).
• To evaluate the efficacy of combining a beta-blocker (propranolol) with a peptide cancer vaccine in a melanoma mouse model.

Main Methods:

• Treatment of murine moMФ and DCs with norepinephrine to assess SNS signaling effects.
• Administration of propranolol in combination with a peptide cancer vaccine to melanoma-bearing mice.
• Analysis of DC maturation, T cell populations, myeloid-derived suppressor cells, and tumor growth.

Main Results:

• Norepinephrine altered moMФ cytokine production but did not affect DCs, which lack beta2-adrenergic receptors.
• Combination therapy enhanced peripheral DC maturation and increased intratumoral CD8+ T cells.
• The combination therapy reduced intratumoral PD-L1+ myeloid-derived suppressor cells and significantly inhibited tumor growth compared to vaccination alone.

Conclusions:

• The SNS differentially regulates APC function, with moMФ being sensitive and DCs being resistant to norepinephrine.
• Propranolol combined with a cancer vaccine demonstrates potent anti-tumor effects by modulating the immune microenvironment.
• This combination therapy holds promise for improving cancer vaccine efficacy and patient survival in melanoma treatment.